Biohaven Pharmaceuticals

Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system.

Industries

Stage

Post IPO Equity

Employees

501-1,000

Links

Org chart

Vlad Coric
CEO & Chairman
Collapse
Cliff Bechtold
President & GM, Biohaven Ireland, Chief Compliance Officer
Charles Conway
Chief Scientific Officer
Elyse Stock
Chief Medical Officer
John Tilton
Chief Commercial Officer
St John Donnie McGrath
Chief of Corporate Strategy & Business Development
Robert Croop
Chief Development Officer, Neurology
Maryellen Mcquade
Chief Talent & Sustainability Officer
Warren Volles
General Counsel & Chief Legal Officer
Marianne Frost
SVP, Regulatory Affairs
Gilbert L'italien
SVP, GHEOR & Epidemiology
Jon Blaskovich
Director, IT